Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Libby MD
Peter Libby MD Advisory Board
Paul Thompson MD
Paul D. Thompson MD Advisory Board
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
See All Experts
featured
Published in Cardiology

Journal Scan / Research · December 31, 2020

12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation

JACC: Cardiovascular Interventions

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Lucas Lauder MD

JACC: Cardiovascular Interventions
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation
JACC Cardiovasc Interv 2020 Dec 28;13(24)2922-2933, M Azizi, J Daemen, MD Lobo, F Mahfoud, ASP Sharp, RE Schmieder, Y Wang, M Saxena, P Lurz, J Sayer, MJ Bloch, J Basile, MA Weber, LC Rump, T Levy, M Sapoval, K Sanghvi, F Rader, NDL Fisher, P Gosse, J Abraham, L Claude, NC Barman, CK McClure, Y Liu, AJ Kirtane

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated